GO
Loading...

Amgen Names Bradway to Replace Nanula as Chief Financial Officer

Amgen, theworld's largest biotechnology company, said after U.S. markets closed Tuesday that it appointed Robert Bradway as chief financial officer.

Bradway replaces Richard Nanula, who is leaving the company to pursue other opportunities.

Bradway, 44, joined Amgen in 2006 as vice president, operations strategy. Prior to joining Amgen, he spent 18 years at Morgan Stanley.

Nanula will remain at Amgen for the next 90 days to assist in the transition.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video